Probiotics for improving the glossiness of pet dog's fur and weight management and application thereof
Through the Enterococcus faecium strain DC-K7, which was isolated from the intestines of healthy dogs, the problems of poor fur gloss and overweight in pet dogs were solved, and significant hair-beauty and weight management was achieved, and it was safe and non-toxic, without producing Antibiotic resistance.
Patent Information
- Application Number
- CN202411226696.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-03
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-09-03
AI Technical Summary
During the growth process, pet dogs have problems with poor fur gloss and overweight obesity. Traditional antibiotics often exacerbate this phenomenon and pose a threat to the ecological environment and human health.
The Enterococcus faecium strain DC-K7 was isolated from the intestines of healthy dogs, and the safety and antibiotic resistance were verified by safety evaluation and functional assays, and its characteristics were determined by 16S rRNA sequencing and whole genome sequencing. Used to improve the gloss and weight management of pet dogs. This probiotic is prepared into lyophilized powder or soft capsules for use by inhibiting the growth of intestinal pathogenic bacteria, increasing the number of beneficial bacteria, and improving the structure of intestinal bacteria.
Significantly improve the gloss and weight management effect of pet dog hair, inhibit the growth of intestinal pathogenic bacteria, increase the number of beneficial intestinal bacteria, improve the structure of intestinal microbial flora, and is safe and does not produce antibiotic resistance.
Smart Images

Figure CN118726209B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a probiotic for improving the glossiness of pet dog fur and managing weight and application thereof, belonging to the field of biotechnology. Background Art
[0002] Dogs are one of the earliest animals domesticated by humans. Initially, humans domesticated dogs for the purpose of guarding homes, assisting in hunting, and reconnaissance. With the evolution of social history, dogs have played more of a role as family companions and are regarded as members of the family. Therefore, people pay more attention to the dog's hair, diet, weight management and other aspects.
[0003] Similar to the problems we humans face, obesity and overweight in companion animals are becoming more and more common. Obesity is a complex, preventable and treatable clinical condition. The root cause is the accumulation of lipids and should be regarded as a disease, which can lead to reduced welfare, serious diseases and shortened life expectancy of companion animals. Overweight and obesity in dogs are associated with a variety of health problems, including cardiopulmonary respiratory, bone, skin, endocrine, urinary and tumor diseases, as well as behavioral problems, such as cardiovascular and respiratory diseases, osteoarthritis (OA) and degenerative joint disease (DJD), diabetes, urinary incontinence and kidney disease, skin diseases, tumors, food guarding, coprophagia, poor social skills, etc. Obesity can also induce insulin resistance and β-cell dysfunction in patients with type 2 diabetes, leading to blood sugar disorders and metabolic disorders. In terms of exercise capacity, excess weight increases the burden on skeletal muscles, causes joint diseases, and reduces exercise capacity or motor dysfunction. In terms of respiratory function, fat compresses the chest cavity, affects lung expansion, and reduces lung ventilation capacity. At the same time, too much fat will increase the risk of anesthesia and make surgery more difficult. Many studies have pointed out the potential benefits of various probiotics in reducing weight, avoiding obesity and improving related diseases. For example, Enterococcus faecium IDCC2102 and Bifidobacterium lactis IDCC4301 can reduce hyperlipidemia caused by a high-fat diet and systemic inflammation and hormonal disorders caused by obesity. Probiotics can promote glycolysis and ATP synthesis through the production of short-chain fatty acids and carboxylic acids, especially when consuming high-calorie foods, enhancing the body's overall energy utilization, thereby preventing lipid accumulation, restoring the stability of the intestinal microbiota, and reducing systemic inflammation caused by a high-fat diet.
[0004] Antibiotics are widely used in medicine, animal husbandry, aquaculture, agriculture and other industries, but they also pose a serious threat to the ecological environment and human health. People pay close attention to the nutrition of companion pets. Probiotic products that have a positive effect and great potential in animal health have attracted more and more attention. Major pet companies have also invested in this field. The market prospects for functional pet food will be broader. Summary of the invention
[0005] In the process of growth, existing pet dogs generally have poor fur glossiness and obesity and overweight, and traditional antibiotics often aggravate this phenomenon. In order to overcome the above shortcomings, the present invention provides a probiotic for improving the fur glossiness and weight management of pet dogs. Safety evaluation proves that the Enterococcus faecium is safe and non-toxic and does not produce antibiotic resistance. Functional tests prove that the pet probiotic can inhibit the growth of intestinal pathogens, has significant fur gloss improvement and weight management effects, and is suitable for promotion and application.
[0006] The present invention achieves the above technical effects through the following technical solutions:
[0007] A probiotic for improving the glossiness of pet dog's hair and managing weight, which is isolated from the intestines of healthy dogs, and the strain is deposited in the China General Microbiological Culture Collection Center (address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing), with a deposit number of CGMCC No. 26839, and is classified as Enterococcus faecium Enterococcus faecium , strain number DC-K7.
[0008] The above-mentioned method for isolating and screening probiotics for improving the glossiness of pet dog's hair and weight management is as follows: the anal swabs of healthy dogs just collected are diluted 10 times in a sterile PBS buffer, and are evenly spread on plates of MRS selective culture medium, cultured anaerobically at 37°C for 24-48h, and then a single clone is picked to inoculate MRS broth culture medium, and then monoclonal colonies are continuously picked for streaking until a pure single colony is obtained.
[0009] The above-mentioned probiotics for improving the glossiness of pet dog's hair and managing weight are characterized by Gram staining, microscopic observation of bacterial morphology and classification and identification using 16S rRNA sequencing. The Enterococcus faecium is a Gram-positive bacterium with milky white colonies. 16S rRNA sequencing identified that it is different from the existing Enterococcus faecium and is a new strain. Enterococcus faecium The homology is 94.32%.
[0010] As mentioned above, the probiotics used to improve the glossiness of pet dog's hair and weight management, Enterococcus faecium ( Enterococcus faecium), through whole genome sequencing, the genome sequence was analyzed and compared with the comprehensive database of virulence factors of pathogenic bacteria (VVFDB) and the comprehensive antibiotic resistance database (CARD) by BLAST, and no virulence factor-related genes and antibiotic resistance genes were found.
[0011] The present invention also requests protection for a use of the above-mentioned pet probiotics, namely, the use of the probiotics in improving the glossiness of pet dog hair. Example 3 of the present invention shows that the probiotics of the present invention have a good hair-beautifying effect. Before the experiment, the hair of the dogs in all groups was rough, dull, and there was hair loss. After the experiment, the hair color of the dogs in the control group did not change significantly; the hair of the dogs in the experimental group became thick and smooth, with a bright luster, and the hair loss was significantly improved; the hair of the dogs in the competitor group was also improved to a certain extent. The above results show that the probiotics in the experimental group have a good hair-beautifying effect.
[0012] The application of the pet probiotics as described above can inhibit the growth of intestinal pathogenic bacteria. Preferably, the intestinal pathogenic bacteria include one or more of Staphylococcus aureus, Escherichia coli, and Streptococcus. The probiotics used for improving the glossiness of pet dog hair and weight management of the present invention have an effect on Staphylococcus aureus ( Staphylococcus aureus ), Escherichia coli ( Escherichia coli ) and intestinal pathogens such as Streptococcus.
[0013] The present invention also claims another use of the above-mentioned probiotics, namely, the use of the probiotics in weight management of pet dogs. Example 3 of the present invention shows that the difference in weight change between the experimental group and the control group and the competitive product group is statistically significant (all P < 0.05), but there is no statistically significant difference in weight change between the competitive product group and the control group (P > 0.05).
[0014] The present invention also claims a biological product containing the above-mentioned Enterococcus faecium. Preferably, the number of Enterococcus faecium in the biological product is ≥ 10×10 9 The biological product can be prepared into a suitable dosage form for use in the above-mentioned probiotic application, preferably a lyophilized powder or soft capsule containing the Enterococcus faecium.
[0015] The present invention isolates and screens out a strain of Enterococcus faecium that has the ability to improve canine intestinal flora from the intestines of healthy dogs. Its colony morphology and molecular biological identification show that it is a new strain of Enterococcus faecium. Through whole genome sequencing, its genome sequence is analyzed and compared with the comprehensive database of virulence factors of pathogenic bacteria (VFDB) and the comprehensive antibiotic resistance database (CARD) by BLAST. No virulence factor-related genes and antibiotic resistance genes were found. The analysis experiment of canine intestinal flora shows that it can increase the number of beneficial bacteria, inhibit the growth of harmful bacteria, and improve the structure of intestinal flora. Specifically, the pet probiotics can increase the proportion of Prevotella, Lactobacillus, and Pseudomonas aeruginosa, and reduce the proportion of Bacteroides.
[0016] Collection information:
[0017] Bacteria name: Enterococcus faecium
[0018] Latin: Enterococcus faecium
[0019] Strain number: DC-K7.
[0020] Classification name: Enterococcus faecium.
[0021] Depository: China General Microbiological Culture Collection Management Center.
[0022] The abbreviation of the collection agency is: CGMCC.
[0023] Address of the preservation institution: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing.
[0024] Deposit number: CGMCC No.26839. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 The microscopic examination results of Enterococcus faecium of the present invention.
[0026] Figure 2 Experiment on the inhibition of intestinal pathogenic bacteria by the probiotics of the present invention.
[0027] Figure 3 The fur condition of dogs in different experimental groups before and after intervention. DETAILED DESCRIPTION
[0028] The present invention is further described below through specific examples, but the examples do not limit the scope of patent protection of the present invention in any way. Equivalent substitutions made by those skilled in the art based on the present invention are all included in the scope of patent protection of the present invention.
[0029] Example 1: Isolation and culture, homology analysis and strain identification of Enterococcus faecium DC-K7 of the present invention
[0030] The freshly collected anal swabs of healthy dogs were diluted 10 times with sterile PBS buffer, and evenly spread on the plates of MRS selective culture medium, and cultured anaerobically at 37℃ for 24-48h. Then pick a single clone to inoculate MRS broth culture medium, and then continuously pick a single clone colony for streaking until a pure single colony is obtained. The screened strains were mixed with glycerol and the bacterial solution, and frozen at -80℃ for standby use. The composition of the MRS selective culture medium per 1000mL culture medium is: 10 g beef protein powder, 10 g fish juice, 5 g yeast extract powder, 20 g glucose, 5 g sodium acetate, 2 g diammonium citrate, 0.1 g Tween 80, 0.58 g magnesium sulfate, 0.28 g manganese sulfate, 1 000 ml distilled water, sterilized at 121℃ for 15 min, adjusted to pH 6.2-6.4, and obtained.
[0031] Screen out the milky white colonies that are the size of a white needle tip and have smooth edges. Perform Gram staining on the isolated and purified bacteria according to the method in the Bergey's Manual of Bacterial Identification. Observe the bacterial morphology under a microscope. The morphology is as follows: Figure 1 Microscopic examination confirmed that the strain was a Gram-positive strain.
[0032] The isolated strain was selected and a pair of universal primers 27f / 1492r were used for 16S rRNA colony PCR amplification. The amplified product was run on 10 g / L agarose gel electrophoresis. The PCR product was recovered with a Gel Extraction Kit and sent to a gene sequencing company for sequencing and identification. 16S rRNA sequencing identified that it was different from the existing Enterococcus faecium and was a new strain. Enterococcus faecium The homology is 94.32%.
[0033] Example 2: Experimental study on the inhibition of intestinal pathogenic bacteria by probiotics for improving the glossiness of pet dog's fur and weight management
[0034] The inhibition zone agar diffusion method was used to study the effects of lactic acid bacteria strains and their metabolites on Staphylococcus aureus ( Staphylococcus aureus ), Escherichia coli ( Escherichia coli First, 0.1 mL of pathogen culture was evenly spread on a common agar plate, and then 10 μL of Enterococcus faecium culture was added to the pre-punched wells. After culturing at 37 °C for 24 h, the inhibition zone was observed. The experimental results are as follows: Figure 2 shown.
[0035] The experimental results show that the probiotics for improving the glossiness of pet dog fur and weight management of the present invention have an effect on Staphylococcus aureus ( Staphylococcus aureus ), Escherichia coli ( Escherichia coli ) and intestinal pathogens such as Streptococcus.
[0036] Example 3: Functional evaluation of the probiotics for improving the glossiness of pet dog fur and weight management of the present invention
[0037] 1. Experimental Animals
[0038] The experiment was conducted at the experimental base of the Shanghai Veterinary Research Institute of the Chinese Academy of Agricultural Sciences. The experimental dogs were Labrador retrievers, totaling 15 dogs.
[0039] 2. Feeding and management methods
[0040] The dogs were randomly divided into five control groups, five competitor groups, and five experimental groups. They were fed with complete feed, with a protein content of 28-34%, and one meal per day. The competitor group used Saccharomyces boulardii probiotics, and the experimental group used Wellcome nutritional supplement probiotic soft capsules, 1g per day, for one month. Adequate drinking water and ventilation of the kennels were ensured, and regular immunization and deworming were performed.
[0041] 3. Probiotic product ingredients
[0042] The competitor group used Saccharomyces boulardii probiotics produced by Qingdao Wangpai Animal Health Products Co., Ltd. (product ingredient analysis guarantee value: brewer's yeast ≥ 1.0 × 10 9 CFU / g, Bacillus subtilis ≥2.0×10 9 CFU / g, Bacillus licheniformis ≥1.0×10 9 CFU / g, Lactobacillus plantarum ≥4.0×10 8 CFU / g, Streptococcus thermophilus ≥5.0×10 7 CFU / g, moisture ≤8%).
[0043] The experimental group used the Enterococcus faecium DC-K7 of the present invention (product component analysis guarantee value: Enterococcus faecium DC-K7 ≥ 10 × 10 9 CFU / g, moisture ≤10%).
[0044] 4. Sample and data collection
[0045] Record the changes in fur and body weight. Take photos of each group's fur at the beginning and end of the experiment, focusing on fur color, the presence of nodules, and luster. Record the fasting weight of each group of dogs daily. All data recording is the responsibility of a dedicated person.
[0046] 5. Statistical Analysis
[0047] SPSS24.0 was used for statistical analysis. Quantitative data were expressed as mean±SD. One-way ANOVA was used to compare the means among groups, and Tukey's method was used for pairwise comparison after ANOVA. P<0.05 was considered statistically significant.
[0048] Experimental results analysis:
[0049] 1. Changes in dog coat color after probiotic intervention
[0050] like Figure 3 As shown in the figure, before the experiment, the dogs in all groups had rough hair, dull luster, and hair loss. After the experiment, the hair color of the dogs in the control group did not change significantly; the hair of the dogs in the experimental group became thicker, smoother, and brighter, and the hair loss was significantly improved; the hair of the dogs in the competitor group also improved to a certain extent. The above results show that the probiotic products in the experimental group have a good hair beautification effect.
[0051] 2. Weight changes after probiotic intervention
[0052] The dogs in each group were weighed before and after the experiment, and the average weight was calculated. The results showed that the weight of the dogs in the control group did not change significantly, with an average weight loss of 0.15 kg; the weight of the dogs in the competitor group decreased, with an average weight loss of 0.67 kg (see Table 1).
[0053] The weight of the dogs in the experimental group decreased significantly, with an average weight loss of 3.15 kg. One-way analysis of variance and Tukey's method were used for pairwise comparison after analysis of variance. The results showed that there were statistically significant differences in weight changes between the experimental group and the control group and the competitive product group (all P < 0.05), but there was no statistically significant difference in weight changes between the competitive product group and the control group (P > 0.05).
[0054] Table 1 Changes in body weight of dogs in each group before and after probiotic intervention
[0055] Starting weight (kg) Final body weight (kg) Average weight loss (kg) Control group 29.43±2.51 29.28±2.65 0.15 Competitive Group 29.28±2.34 28.61±2.46 0.67 Experimental Group 29.53±2.89 26.38±1.31 3.15
[0056] Example 4: Safety experiment of Enterococcus faecium DC-K7 for improving canine intestinal flora of the present invention
[0057] The whole genome shotgun (WGS) method was used to construct libraries with different insert fragments, and then the constructed libraries were sequenced separately using the second-generation sequencing technology based on the Illumina MiSeq sequencing platform combined with the third-generation single-molecule sequencing technology based on the PacBio sequencing platform. The second-generation high-throughput sequencing data were assembled using A5-miseq version 20160825 software and SPAdes genome assembler v3.11.1 software to obtain contigs and scaffolds sequences. The third-generation single-molecule sequencing data were assembled using HGAP4 software and CANU (V1.6) software to obtain scaffold sequences. The contigs obtained by splicing the second-generation and third-generation sequencing data were analyzed for colinearity using MUMmer (v3) software to confirm the assembly results of the two, determine the positional relationship between contigs, and fill the gaps between contigs. Finally, the results were corrected again using pilon (version 1.22) software, and the complete sequence was finally spliced. The presence of virulence factor-related genes in the sequenced genome was analyzed by BLAST comparison with 2599 experimentally confirmed virulence factor-related genes collected in the comprehensive database of Virulence Factors of Pathogenic Bacteria (VFDB). The presence of antibiotic resistance genes in the sequenced genome sequence was analyzed by BLAST comparison with antibiotic resistance genes in the Comprehensive Antibiotic Resistance Database (CARD).
[0058] Through BLAST comparison, it was detected that there were no virulence factor-related genes in the whole genome of the Enterococcus faecium DC-K7 used for improving the canine intestinal flora of the present invention, and there were no antibiotic resistance genes in the genome sequence, which shows that the Enterococcus faecium is highly safe when used for regulating the intestinal flora of pets, and long-term use will not produce antibiotic resistance.
[0059] The present invention studies the effect of Enterococcus faecium DC-K7 on the community structure of canine intestinal flora, and confirms the effect of Enterococcus faecium DC-K7 in improving the condition of canine fur and helping weight management. Intestinal flora imbalance will not only reduce the proportion of beneficial intestinal bacteria and increase the number of pathogenic bacteria, but may also further damage the intestinal barrier function, causing bacterial toxins to enter the blood circulation system and cause inflammation. The use of Enterococcus faecium DC-K7 can inhibit the growth of intestinal pathogens in canine intestinal flora, which is an effective way to beautify the fur and hair of pet dogs, control weight, and increase animal welfare.
Claims
1. A probiotic for improving the glossiness of pet dog fur and weight management, which is Enterococcus faecium, the strain is deposited in the China General Microbiological Culture Collection Center, and the deposit number is CGMCC No.26839.
2. The probiotics for improving the glossiness of pet dog hair and managing weight according to claim 1, It is characterized in that The Enterococcus faecium is a Gram-positive bacterium with milky white colonies.
3. The probiotics for improving the glossiness of pet dog hair and managing weight according to claim 1, It is characterized in that The whole genome of Enterococcus faecium has no virulence factor-related genes and antibiotic resistance genes.
4. Use of the probiotics according to claim 1 in improving the glossiness of pet dog hair.
5. The use according to claim 4, It is characterized in that The probiotics can inhibit the growth of intestinal pathogenic bacteria.
6. The use according to claim 5, It is characterized in that The intestinal pathogenic bacteria include one or more of Staphylococcus aureus, Escherichia coli and Streptococcus.
7. Use of the probiotics according to claim 1 in weight management of pet dogs.
8. A biological product comprising the Enterococcus faecium according to claim 1.
9. The biological product comprising Enterococcus faecium according to claim 8, It is characterized in that The number of Enterococcus faecium in the biological product is ≥10×10 9 CFU / g.
10. The biological product comprising Enterococcus faecium according to claim 8, It is characterized in that The biological product is a freeze-dried powder or soft capsule containing the Enterococcus faecium.
Citation Information
Patent Citations
Enterococcus faecium capable of improving carbohydrate decomposition capability and application of enterococcus faecium in regulation of pet intestinal micro-ecological environment
CN116836894A
Composition for preventing or treating obesity of companion animal comprising Enterococcus faecium IDCC 2102
KR102531190B1
